BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shi C, Hruban RH, Klein AP. Familial pancreatic cancer. Arch Pathol Lab Med. 2009;133:365-374. [PMID: 19260742 DOI: 10.5858/133.3.365] [Cited by in Crossref: 17] [Cited by in F6Publishing: 75] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet. 2011;378:607-620. [PMID: 21620466 DOI: 10.1016/so140-6736(10)62307-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Wolfgang CL, Herman JM, Laheru DA, Klein AP, Erdek MA, Fishman EK, Hruban RH. Recent progress in pancreatic cancer. CA Cancer J Clin. 2013;63:318-348. [PMID: 23856911 DOI: 10.3322/caac.21190] [Cited by in Crossref: 479] [Cited by in F6Publishing: 473] [Article Influence: 59.9] [Reference Citation Analysis]
3 Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. The Lancet 2004;363:1049-57. [DOI: 10.1016/s0140-6736(04)15841-8] [Cited by in Crossref: 1360] [Cited by in F6Publishing: 672] [Article Influence: 80.0] [Reference Citation Analysis]
4 Chiaro MD, Segersvärd R, Lohr M, Verbeke C. Early detection and prevention of pancreatic cancer: Is it really possible today? World J Gastroenterol 2014; 20(34): 12118-12131 [PMID: 25232247 DOI: 10.3748/wjg.v20.i34.12118] [Cited by in CrossRef: 73] [Cited by in F6Publishing: 60] [Article Influence: 10.4] [Reference Citation Analysis]
5 Van Tran T, Van Dao T, Nguyen KD, van Ta T, Vu KT, Trinh SH, Nguyen HC, Bui OT, Nguyen QT, Vu HD, Nguyen HL, Tran HT. Risk factors of Pancreatic Cancer in Vietnam: A Matched Case-Control Hospital-Based Study. Cancer Control 2021;28:1073274821989320. [PMID: 33517745 DOI: 10.1177/1073274821989320] [Reference Citation Analysis]
6 Kanji ZS, Gallinger S. Diagnosis and management of pancreatic cancer. CMAJ. 2013;185:1219-1226. [PMID: 23610017 DOI: 10.1503/cmaj.121368] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
7 Poruk KE, Firpo MA, Adler DG, Mulvihill SJ. Screening for pancreatic cancer: why, how, and who? Ann Surg 2013;257:17-26. [PMID: 22895395 DOI: 10.1097/SLA.0b013e31825ffbfb] [Cited by in Crossref: 120] [Cited by in F6Publishing: 64] [Article Influence: 15.0] [Reference Citation Analysis]
8 Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet. 2011;378:607-620. [PMID: 21620466 DOI: 10.1016/s0140-6736(10)62307-0] [Cited by in Crossref: 1377] [Cited by in F6Publishing: 849] [Article Influence: 137.7] [Reference Citation Analysis]
9 Vincent DF, Yan KP, Treilleux I, Gay F, Arfi V, Kaniewski B, Marie JC, Lepinasse F, Martel S, Goddard-Leon S. Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas. PLoS Genet. 2009;5:e1000575. [PMID: 19629168 DOI: 10.1371/journal.pgen.1000575.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Roberts NJ, Klein AP. Genome-wide sequencing to identify the cause of hereditary cancer syndromes: with examples from familial pancreatic cancer. Cancer Lett 2013;340:227-33. [PMID: 23196058 DOI: 10.1016/j.canlet.2012.11.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
11 Goel G, Sun W. Novel approaches in the management of pancreatic ductal adenocarcinoma: potential promises for the future. J Hematol Oncol. 2015;8:44. [PMID: 25935754 DOI: 10.1186/s13045-015-0141-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
12 Falzon M, Bhatia V. Role of Parathyroid Hormone-Related Protein Signaling in Chronic Pancreatitis. Cancers (Basel) 2015;7:1091-108. [PMID: 26095761 DOI: 10.3390/cancers7020826] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
13 Kanno A, Masamune A, Hanada K, Kikuyama M, Kitano M. Advances in Early Detection of Pancreatic Cancer. Diagnostics (Basel) 2019;9:E18. [PMID: 30764550 DOI: 10.3390/diagnostics9010018] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
14 Tischkowitz MD, Sabbaghian N, Hamel N, Borgida A, Rosner C, Taherian N, Srivastava A, Holter S, Rothenmund H, Ghadirian P. Analysis of the gene coding for the BRCA2-interacting protein PALB2 in familial and sporadic pancreatic cancer. Gastroenterology. 2009;137:1183-1186. [PMID: 19635604 DOI: 10.1053/j.gastro.2009.06.055] [Cited by in Crossref: 101] [Cited by in F6Publishing: 94] [Article Influence: 8.4] [Reference Citation Analysis]
15 Iacobuzio-Donahue CA, Velculescu VE, Wolfgang CL, Hruban RH. Genetic basis of pancreas cancer development and progression: insights from whole-exome and whole-genome sequencing. Clin Cancer Res. 2012;18:4257-4265. [PMID: 22896692 DOI: 10.1158/1078-0432.ccr-12-0315] [Cited by in Crossref: 85] [Cited by in F6Publishing: 53] [Article Influence: 10.6] [Reference Citation Analysis]
16 Vikram R, Balachandran A. Imaging in staging and management of pancreatic ductal adenocarcinoma. Indian J Surg Oncol 2011;2:78-87. [PMID: 22693399 DOI: 10.1007/s13193-010-0017-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
17 Ibrahim IS, Bonsing BA, Swijnenburg RJ, Welling L, Veenendaal RA, Wasser MN, Morreau H, Inderson A, Vasen HF. Dilemmas in the management of screen-detected lesions in patients at high risk for pancreatic cancer. Fam Cancer 2017;16:111-5. [PMID: 27406244 DOI: 10.1007/s10689-016-9915-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
18 Morrison AH, Byrne KT, Vonderheide RH. Immunotherapy and Prevention of Pancreatic Cancer. Trends Cancer 2018;4:418-28. [PMID: 29860986 DOI: 10.1016/j.trecan.2018.04.001] [Cited by in Crossref: 81] [Cited by in F6Publishing: 83] [Article Influence: 27.0] [Reference Citation Analysis]
19 Sahin IH, Lowery MA, Stadler ZK, Salo-Mullen E, Iacobuzio-Donahue CA, Kelsen DP, O'Reilly EM. Genomic instability in pancreatic adenocarcinoma: a new step towards precision medicine and novel therapeutic approaches. Expert Rev Gastroenterol Hepatol. 2016;10:893-905. [PMID: 26881472 DOI: 10.1586/17474124.2016.1153424] [Cited by in Crossref: 11] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
20 Capasso M, Franceschi M, Rodriguez-Castro KI, Crafa P, Cambiè G, Miraglia C, Barchi A, Nouvenne A, Leandro G, Meschi T, De' Angelis GL, Di Mario F. Epidemiology and risk factors of pancreatic cancer. Acta Biomed 2018;89:141-6. [PMID: 30561407 DOI: 10.23750/abm.v89i9-S.7923] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
21 Hruban RH, Canto MI, Goggins M, Schulick R, Klein AP. Update on familial pancreatic cancer. Adv Surg. 2010;44:293-311. [PMID: 20919528 DOI: 10.1016/j.yasu.2010.05.011] [Cited by in Crossref: 159] [Cited by in F6Publishing: 140] [Article Influence: 14.5] [Reference Citation Analysis]
22 Feldmann G, Karikari C, dal Molin M, Duringer S, Volkmann P, Bartsch DK, Bisht S, Koorstra JB, Brossart P, Maitra A, Fendrich V. Inactivation of Brca2 cooperates with Trp53(R172H) to induce invasive pancreatic ductal adenocarcinomas in mice: a mouse model of familial pancreatic cancer. Cancer Biol Ther 2011;11:959-68. [PMID: 21455033 DOI: 10.4161/cbt.11.11.15534] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
23 Hong SM, Heaphy CM, Shi C, Eo SH, Cho H, Meeker AK, Eshleman JR, Hruban RH, Goggins M. Telomeres are shortened in acinar-to-ductal metaplasia lesions associated with pancreatic intraepithelial neoplasia but not in isolated acinar-to-ductal metaplasias. Mod Pathol 2011;24:256-66. [PMID: 20871595 DOI: 10.1038/modpathol.2010.181] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
24 O'Neill RS, Meiser B, Emmanuel S, Williams DB, Stoita A. Long-term positive psychological outcomes in an Australian pancreatic cancer screening program. Fam Cancer 2020;19:23-35. [PMID: 31625003 DOI: 10.1007/s10689-019-00147-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
25 Prom-Wormley EC, Clifford JS, Bourdon JL, Barr P, Blondino C, Ball KM, Montgomery J, Davis JK, Real JE, Edwards AC, Thiselton DL, Creighton GC, Wilson D, Newbille C. Developing community-based health education strategies with family history: Assessing the association between community resident family history and interest in health education. Soc Sci Med 2021;271:112160. [PMID: 30862375 DOI: 10.1016/j.socscimed.2019.02.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
26 Seicean A, Petrusel L, Seicean R. New targeted therapies in pancreatic cancer. World J Gastroenterol 2015; 21(20): 6127-6145 [PMID: 26034349 DOI: 10.3748/wjg.v21.i20.6127] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 36] [Article Influence: 5.0] [Reference Citation Analysis]
27 Roberts NJ, Jiao Y, Yu J, Kopelovich L, Petersen GM, Bondy ML, Gallinger S, Schwartz AG, Syngal S, Cote ML. ATM mutations in patients with hereditary pancreatic cancer. Cancer Discov. 2012;2:41-46. [PMID: 22585167 DOI: 10.1158/2159-8290.cd-11-0194] [Cited by in Crossref: 318] [Cited by in F6Publishing: 183] [Article Influence: 31.8] [Reference Citation Analysis]
28 Isherwood J, Bilku D, Metcalfe MS, Dennison AR, Garcea G. Treatment Access and Survival Amongst British Asians with Pancreatic Cancer. World J Surg 2017;41:546-51. [PMID: 27600708 DOI: 10.1007/s00268-016-3707-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Blanco VM, Latif T, Chu Z, Qi X. Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted Nanovesicles. Transl Oncol 2015;8:196-203. [PMID: 26055177 DOI: 10.1016/j.tranon.2015.03.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
30 Lynch HT, Lynch JF, Lanspa SJ. Familial pancreatic cancer. Cancers (Basel). 2010;2:1861-1883. [PMID: 24281205 DOI: 10.3390/cancers2041861] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
31 Hong SM, Park JY, Hruban RH, Goggins M. Molecular signatures of pancreatic cancer. Arch Pathol Lab Med 2011;135:716-27. [PMID: 21631264 DOI: 10.5858/2010-0566-RA.1] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
32 Laeseke PF, Chen R, Jeffrey RB, Brentnall TA, Willmann JK. Combining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions. Radiology. 2015;277:644-661. [PMID: 26599925 DOI: 10.1148/radiol.2015141020] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
33 Yeo TP, Lavu H, Nevler A, Brumbaugh J, Vicchairelli D, Winter JM, Brody JR, Yeo CJ. Precious Data: Interim Report from the Jefferson Pancreas Tumor Registry. J Pancreat Cancer 2018;4:17-24. [PMID: 30631853 DOI: 10.1089/pancan.2018.0004] [Reference Citation Analysis]
34 Sabater-Molina M, Navarro-Peñalver M, Muñoz-Esparza C, Esteban-Gil Á, Santos-Mateo JJ, Gimeno JR. Genetic Factors Involved in Cardiomyopathies and in Cancer. J Clin Med 2020;9:E1702. [PMID: 32498335 DOI: 10.3390/jcm9061702] [Reference Citation Analysis]
35 McNamara GPJ, Ali KN, Vyas S, Huynh T, Nyland M, Almanza D, Laronga C, Klapman J, Permuth JB. Characteristics and Clinical Outcomes of Individuals at High Risk for Pancreatic Cancer: A Descriptive Analysis from a Comprehensive Cancer Center. Gastrointest Disord (Basel) 2019;1:106-19. [PMID: 32601617 DOI: 10.3390/gidisord1010008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Tewari M. Pancreatic Cancer: a Challenge to Cure. Indian J Surg 2015;77:350-7. [PMID: 26722196 DOI: 10.1007/s12262-015-1369-6] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
37 O'Neill RS, Stoita A. Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket? World J Gastroenterol 2021; 27(26): 4045-4087 [PMID: 34326612 DOI: 10.3748/wjg.v27.i26.4045] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Vaz J, Andersson R. Intervention on toll-like receptors in pancreatic cancer. World J Gastroenterol 2014; 20(19): 5808-5817 [PMID: 24914341 DOI: 10.3748/wjg.v20.i19.5808] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
39 Wörmann SM, Algül H. Risk Factors and Therapeutic Targets in Pancreatic Cancer. Front Oncol 2013;3. [DOI: 10.3389/fonc.2013.00282] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
40 Weledji EP, Enoworock G, Mokake M, Sinju M. How Grim is Pancreatic Cancer? Oncol Rev 2016;10:294. [PMID: 27471581 DOI: 10.4081/oncol.2016.294] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
41 Chakraborty S, Baine MJ, Sasson AR, Batra SK. Current status of molecular markers for early detection of sporadic pancreatic cancer. Biochim Biophys Acta 2011;1815:44-64. [PMID: 20888394 DOI: 10.1016/j.bbcan.2010.09.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 57] [Article Influence: 1.9] [Reference Citation Analysis]
42 Lin QJ, Yang F, Jin C, Fu DL. Current status and progress of pancreatic cancer in China. World J Gastroenterol 2015; 21(26): 7988-8003 [PMID: 26185370 DOI: 10.3748/wjg.v21.i26.7988] [Cited by in CrossRef: 127] [Cited by in F6Publishing: 129] [Article Influence: 21.2] [Reference Citation Analysis]
43 Tokura M, Kamisawa T, Kuwata G, Koizumi K, Kurata M, Hishima T. Pancreatic Cancer as the Fourth Cancer in a Patient With Peutz-Jeghers Syndrome and a History of Familial Pancreatic Cancer. Pancreas 2011;40:169-70. [DOI: 10.1097/mpa.0b013e3181ea6147] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
44 Sharma C, Eltawil KM, Renfrew PD, Walsh MJ, Molinari M. Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010. World J Gastroenterol 2011; 17(7): 867-897 [PMID: 21412497 DOI: 10.3748/wjg.v17.i7.867] [Cited by in CrossRef: 119] [Cited by in F6Publishing: 109] [Article Influence: 11.9] [Reference Citation Analysis]
45 Ibrahim AM, Wang YH. Viro-immune therapy: A new strategy for treatment of pancreatic cancer. World J Gastroenterol 2016; 22(2): 748-763 [PMID: 26811622 DOI: 10.3748/wjg.v22.i2.748] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
46 Kiss K, Baghy K, Spisák S, Szanyi S, Tulassay Z, Zalatnai A, Löhr JM, Jesenofsky R, Kovalszky I, Firneisz G. Chronic hyperglycemia induces trans-differentiation of human pancreatic stellate cells and enhances the malignant molecular communication with human pancreatic cancer cells. PLoS One. 2015;10:e0128059. [PMID: 26010611 DOI: 10.1371/journal.pone.0128059] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
47 Liszka L, Pająk J, Mrowiec S, Zielińska-Pająk E, Gołka D, Lampe P. Precursor lesions of early onset pancreatic cancer. Virchows Arch 2011;458:439-51. [PMID: 21369801 DOI: 10.1007/s00428-011-1056-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
48 Becker AE, Hernandez YG, Frucht H, Lucas AL. Pancreatic ductal adenocarcinoma: Risk factors, screening, and early detection. World J Gastroenterol 2014; 20(32): 11182-11198 [PMID: 25170203 DOI: 10.3748/wjg.v20.i32.11182] [Cited by in CrossRef: 160] [Cited by in F6Publishing: 141] [Article Influence: 22.9] [Reference Citation Analysis]
49 Gold DV, Goggins M, Modrak DE, Newsome G, Liu M, Shi C, Hruban RH, Goldenberg DM. Detection of early-stage pancreatic adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2010;19:2786-2794. [PMID: 20810605 DOI: 10.1158/1055-9965.epi-10-0667] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
50 Rossi ML, Rehman AA, Gondi CS. Therapeutic options for the management of pancreatic cancer. World J Gastroenterol 2014; 20(32): 11142-11159 [PMID: 25170201 DOI: 10.3748/wjg.v20.i32.11142] [Cited by in CrossRef: 75] [Cited by in F6Publishing: 68] [Article Influence: 10.7] [Reference Citation Analysis]
51 Winter K, Talar-Wojnarowska R, Dąbrowski A, Degowska M, Durlik M, Gąsiorowska A, Głuszek S, Jurkowska G, Kaczka A, Lampe P, Marek T, Nasierowska-Guttmejer A, Nowakowska-Duława E, Rydzewska G, Strzelczyk J, Śledziński Z, Małecka-Panas E. Diagnostic and therapeutic recommendations in pancreatic ductal adenocarcinoma. Recommendations of the Working Group of the Polish Pancreatic Club. Prz Gastroenterol 2019;14:1-18. [PMID: 30944673 DOI: 10.5114/pg.2019.83422] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
52 Barton JG, Schnelldorfer T, Lohse CM, Bamlet WR, Rabe KG, Petersen GM, Donohue JH, Farnell MB, Kendrick ML, Nagorney DM, Lombardo KM, Que FG. Patterns of pancreatic resection differ between patients with familial and sporadic pancreatic cancer. J Gastrointest Surg 2011;15:836-42. [PMID: 21359597 DOI: 10.1007/s11605-011-1417-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
53 Petersen GM, Amundadottir L, Fuchs CS, Kraft P, Stolzenberg-Solomon RZ, Jacobs KB, Arslan AA, Bueno-de-Mesquita HB, Gallinger S, Gross M. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet. 2010;42:224-228. [PMID: 20101243 DOI: 10.1038/ng.522] [Cited by in Crossref: 428] [Cited by in F6Publishing: 393] [Article Influence: 38.9] [Reference Citation Analysis]
54 Iacobuzio-Donahue CA. Genetic evolution of pancreatic cancer: lessons learnt from the pancreatic cancer genome sequencing project. Gut. 2012;61:1085-1094. [PMID: 21749982 DOI: 10.1136/gut.2010.236026] [Cited by in Crossref: 89] [Cited by in F6Publishing: 82] [Article Influence: 8.9] [Reference Citation Analysis]
55 Huang X, Zheng J, Li J, Che X, Tan W, Tan W, Shao M, Cheng X, Du Z, Zhao Y, Wang C, Wu C, Lin D. Functional role of BTB and CNC Homology 1 gene in pancreatic cancer and its association with survival in patients treated with gemcitabine. Theranostics 2018;8:3366-79. [PMID: 29930735 DOI: 10.7150/thno.23978] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
56 Vincent DF, Yan KP, Treilleux I, Gay F, Arfi V, Kaniewski B, Marie JC, Lepinasse F, Martel S, Goddard-Leon S. Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas. PLoS Genet. 2009;5:e1000575. [PMID: 19629168 DOI: 10.1371/journal.pgen.1000575] [Cited by in Crossref: 75] [Cited by in F6Publishing: 82] [Article Influence: 6.3] [Reference Citation Analysis]
57 Norris AL, Roberts NJ, Jones S, Wheelan SJ, Papadopoulos N, Vogelstein B, Kinzler KW, Hruban RH, Klein AP, Eshleman JR. Familial and sporadic pancreatic cancer share the same molecular pathogenesis. Fam Cancer. 2015;14:95-103. [PMID: 25240578 DOI: 10.1007/s10689-014-9755-y] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 6.3] [Reference Citation Analysis]
58 Danielsson K, Ansari D, Andersson R. Personalizing pancreatic cancer medicine: what are the challenges? Personalized Medicine 2013;10:45-59. [DOI: 10.2217/pme.12.111] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
59 Duvillié B, Kourdoughli R, Druillennec S, Eychène A, Pouponnot C. Interplay Between Diabetes and Pancreatic Ductal Adenocarcinoma and Insulinoma: The Role of Aging, Genetic Factors, and Obesity. Front Endocrinol (Lausanne) 2020;11:563267. [PMID: 33101198 DOI: 10.3389/fendo.2020.563267] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Ushio J, Kanno A, Ikeda E, Ando K, Nagai H, Miwata T, Kawasaki Y, Tada Y, Yokoyama K, Numao N, Tamada K, Lefor AK, Yamamoto H. Pancreatic Ductal Adenocarcinoma: Epidemiology and Risk Factors. Diagnostics (Basel) 2021;11:562. [PMID: 33804776 DOI: 10.3390/diagnostics11030562] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Lami G, Biagini MR, Galli A. Endoscopic ultrasonography for surveillance of individuals at high risk for pancreatic cancer. World J Gastrointest Endosc 2014; 6(7): 272-285 [PMID: 25031786 DOI: 10.4253/wjge.v6.i7.272] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
62 Urayama S. Pancreatic cancer early detection: Expanding higher-risk group with clinical and metabolomics parameters. World J Gastroenterol 2015; 21(6): 1707-1717 [PMID: 25684935 DOI: 10.3748/wjg.v21.i6.1707] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
63 Ohmoto A, Yachida S, Morizane C. Genomic Features and Clinical Management of Patients with Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer. Int J Mol Sci. 2019;20. [PMID: 30699894 DOI: 10.3390/ijms20030561] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
64 Esposito I, Konukiewitz B, Schlitter AM, Klöppel G. Pathology of pancreatic ductal adenocarcinoma: Facts, challenges and future developments. World J Gastroenterol 2014; 20(38): 13833-13841 [PMID: 25320520 DOI: 10.3748/wjg.v20.i38.13833] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 32] [Article Influence: 6.3] [Reference Citation Analysis]
65 Rawla P, Sunkara T, Gaduputi V. Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World J Oncol. 2019;10:10-27. [PMID: 30834048 DOI: 10.14740/wjon1166] [Cited by in Crossref: 473] [Cited by in F6Publishing: 448] [Article Influence: 236.5] [Reference Citation Analysis]
66 Wolfgang CL, Herman JM, Laheru DA, Klein AP, Erdek MA, Fishman EK, Hruban RH. Recent progress in pancreatic cancer. CA Cancer J Clin. 2013;63:318-348. [PMID: 23856911 DOI: 10.1002/caac.21190] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
67 Singhi AD, Ishida H, Ali SZ, Goggins M, Canto M, Wolfgang CL, Meriden Z, Roberts N, Klein AP, Hruban RH. A histomorphologic comparison of familial and sporadic pancreatic cancers. Pancreatology. 2015;15:387-391. [PMID: 25959245 DOI: 10.1016] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
68 Macklin SK, Kasi PM, Jackson JL, Hines SL. Incidence of Pathogenic Variants in Those With a Family History of Pancreatic Cancer. Front Oncol 2018;8:330. [PMID: 30186770 DOI: 10.3389/fonc.2018.00330] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
69 Hong SM, Vincent A, Kanda M, Leclerc J, Omura N, Borges M, Klein AP, Canto MI, Hruban RH, Goggins M. Genome-wide somatic copy number alterations in low-grade PanINs and IPMNs from individuals with a family history of pancreatic cancer. Clin Cancer Res 2012;18:4303-12. [PMID: 22723370 DOI: 10.1158/1078-0432.CCR-12-1075] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
70 Oberstein PE, Olive KP. Pancreatic cancer: why is it so hard to treat? Therap Adv Gastroenterol. 2013;6:321-337. [PMID: 23814611 DOI: 10.1177/1756283x13478680] [Cited by in Crossref: 155] [Cited by in F6Publishing: 104] [Article Influence: 19.4] [Reference Citation Analysis]
71 Lochan R, Reeves HL, Daly AK, Charnley RM. The role of tobacco-derived carcinogens in pancreas cancer. ISRN Oncol 2011;2011:249235. [PMID: 22084727 DOI: 10.5402/2011/249235] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
72 Saraee A, Vahedian-Ardakani J, Saraee E, Pakzad R, Wadji MB. Whipple procedure: a review of a 7-year clinical experience in a referral center for hepatobiliary and pancreas diseases. World J Surg Oncol 2015;13:98. [PMID: 25885408 DOI: 10.1186/s12957-015-0523-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
73 Ghiorzo P. Genetic predisposition to pancreatic cancer. World J Gastroenterol 2014; 20(31): 10778-10789 [PMID: 25152581 DOI: 10.3748/wjg.v20.i31.10778] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 44] [Article Influence: 7.0] [Reference Citation Analysis]
74 Overbeek KA, Cahen DL, Canto MI, Bruno MJ. Surveillance for neoplasia in the pancreas. Best Pract Res Clin Gastroenterol 2016;30:971-86. [PMID: 27938791 DOI: 10.1016/j.bpg.2016.10.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
75 Macklin-Mantia SK, Hines SL, Kasi PM. Retrospective review of outcomes in patients with DNA-damage repair related pancreatic cancer. Hered Cancer Clin Pract 2020;18:17. [PMID: 32793315 DOI: 10.1186/s13053-020-00148-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Lai E, Ziranu P, Spanu D, Dubois M, Pretta A, Tolu S, Camera S, Liscia N, Mariani S, Persano M, Migliari M, Donisi C, Demurtas L, Pusceddu V, Puzzoni M, Scartozzi M. BRCA-mutant pancreatic ductal adenocarcinoma. Br J Cancer 2021. [PMID: 34262146 DOI: 10.1038/s41416-021-01469-9] [Reference Citation Analysis]